Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …

Poor glycaemic control in type 2 diabetes (T2D) is a global problem despite the availability
of numerous glucose‐lowering therapies and clear guidelines for T2D management …

Diabetes mellitus is a chronic disease characterized by high social, economic and health
burden, mostly due to the high incidence and morbidity of diabetes complications …

Rates of population ageing are unprecedented and this, combined with the progressive
urbanization of lifestyles, has led to a dramatic shift in the epidemiology of diabetes towards …

Background: Clinical Inertia is defined as “failure of health care providers to initiate or
intensify therapy according to current guidelines”. This phenomenon is gaining increasing …

Purpose Clinical inertia and medication non-adherence are thought to contribute largely to
the suboptimal glycemic control in many patients with type 2 diabetes. The present review …

Type 2 diabetes is a progressive disorder characterized by increasing hyperglycemia and
the need to gradually intensify therapy in order to achieve and maintain glycemic control …

Aims To determine the patterns and predictors of treatment intensification in patients with
type 2 diabetes on≥ 2 non‐insulin antidiabetic drugs (NIAD s) and inadequate glycaemic …

This review seeks to establish, through the recent available literature, the prevalence of
therapeutic intensification delay and its sequences in poorly controlled Type 2 Diabetes …

Introduction Basal insulin (BI) plays an important role in treating type 2 diabetes (T2D),
especially when oral antidiabetic (OAD) medications are insufficient for glycemic control. We …